Alnylam Pharmaceuticals
ALNY
ALNY
210 hedge funds and large institutions have $2.99B invested in Alnylam Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 76 increasing their positions, 72 reducing their positions, and 77 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding in top 10
Funds holding in top 10: →
19% less funds holding
Funds holding: 258 → 210 (-48)
43% less capital invested
Capital invested by funds: $5.24B → $2.99B (-$2.25B)
53% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 77
Holders
210
Holding in Top 10
8
Calls
$34.4M
Puts
$37.3M
Top Buyers
| 1 | +$147M | |
| 2 | +$29M | |
| 3 | +$12.8M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$11.9M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$11.3M |
Top Sellers
| 1 | -$53M | |
| 2 | -$33.3M | |
| 3 | -$18.4M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$16.3M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$15M |